[1]
J. S. Tronieri, “WEIGHT LOSS WITH LIRAGLUTIDE 3.0 mg VERSUS PLACEBO FOR INDIVIDUALS WHO ADHERE TO THE TRIAL DRUG: A SECONDARY ANALYSIS FROM SCALE IBT”, J ASEAN Fed Endocr Soc, vol. 34, no. 2, pp. 46–47, Jun. 2022.